Fangming Lin, MD
On the web
Overview
Dr. Fangming Lin joined CUMC in June 2011 as the Division Director of Pediatric Nephrology after 10 years of serving University of Texas Southwestern Medical Center at Dallas. She received her MD degree from Fujian Medical University in China and her PhD degree in Pharmacology at New York Medical College. Dr. Lin underwent pediatric residency training at New York University Medical Center and pediatric nephrology fellowship training at Seattle Children’s Hospital of the University of Washington.
As a physician scientist, Dr. Lin has a strong interest in both patient care and science and discovery. She is passionate and experienced in treating children with congenital kidney conditions as well as acquired kidney diseases. Her laboratory research focuses on the understanding and better treatment for acute and chronic kidney disease. She is the first recipient of the Norman Siegel Pediatric Research Grant Award jointly issued by the American Society of Nephrology (ASN) and the American Society of Pediatric Nephrology (ASPN) in 2006 - a humbling selection of which she is proud. Dr. Lin has also served on several committees at the national and international levels.
Areas of Expertise / Conditions Treated
- Glomerulonephritis
- Hematuria
- Hemodialysis
- Hemolytic Uremic Syndrome
- Hypertension
- Kidney Stones
- Kidney Transplant
- Kidney Transplantation
- Nephrotic Syndrome
- Peritoneal Dialysis
- Proteinuria
Academic Appointments
- Rustin McIntosh Professor of Pediatrics
Administrative Titles
- Chief, Division of Pediatric Nephrology
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian Morgan Stanley Children's Hospital
- NewYork-Presbyterian Allen Hospital
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
Affinity Health Plan
Amerigroup of New Jersey
Cigna
Emblem/GHI
Emblem/HIP
Empire Blue Cross/Blue Shield
Empire Blue Cross Blue Shield HealthPlus
Fidelis Care
Healthfirst
Local 1199
MagnaCare (National)
Medicare
Multiplan
MVP Health Care
RiverSpring
UnitedHealthcare
VNSNY CHOICE
WellCare
World Trade Center Health Plan
Credentials & Experience
Education & Training
- Fujian Medical University (China)
- Internship: New York University Medical Center
- Residency: New York University Medical Center
- Fellowship: Seattle Children's Hospital
Board Certifications
- Pediatrics
- Pediatric Nephrology
Research
Our laboratory studies kidney injury and repair using a variety of mouse models. We are currently focusing on the function and molecular regulation of epithelial autophagy. We have shown that following urinary tract obstruction or ischemic injury to the kidney, autophagy is activated in a regulated and dynamic fashion for renal tubular survival and repair. A stress-responsive transcription factor FoxO3 plays an important role in regulating the stress response during the acute injury and the progression to chronic kidney disease. Our goal is to use the knowledge learned from animal studies to help design methods that integrate modulation of autophagy into prevention and treatment for human kidney disease.
Grants
GENERATION OF NEW MOUSE MODELS OF LOW NEPHRON NUMBERS TO UNDERSTAND PATHOGENESIS OF AKI AND CKD IN HUMANS BORN PRETERM (Federal Gov)
Feb 15 2019 - November 30 2022
For a complete list of publications, please visit PubMed.gov(link is external and opens in a new window)